Featuring a CME/CE/CPE-certified on-demand Webcast and downloadable slideset, this program equips clinicians with evidence-based strategies to optimize the care of patients with EGFR-mutated advanced NSCLC in the first-line setting and beyond.
Review the latest evidence for optimal use of first-line agents in the management of EGFR-mutated advanced NSCLC.
Gain expert insights on the mechanisms of acquired resistance and subsequent treatment algorithms for patients with recurrent EGFR-mutated NSCLC.
Examine emerging data on investigational combinations of EGFR TKIs with immunotherapy, chemotherapy, and other targeted agents for treatment of EGFR-mutated NSCLC.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.